Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric Approach
mCCI provides a more accurate assessment of comorbidities than the standard CCI and is associated with survival, hence it can contribute to designing patient-tailored therapeutic strategies.
Authors
- Cristiano Quintini (ORCID: https://orcid.org/0000-0002-6802-1436)
- Barbara Antonelli (ORCID: https://orcid.org/0000-0001-8435-1294)
- Mariangela Bruccoleri (ORCID: https://orcid.org/0000-0001-7400-4854)
- L. Canova
- Pierpaolo Biondetti (ORCID: https://orcid.org/0000-0002-2737-2053)
- Elia Fracas (ORCID: https://orcid.org/0009-0000-1212-3954)
- Angelo Sangiovanni
- Pietro Lampertico
- Massimo Iavarone
- Gianpaolo Carrafiello
- Eleonora Alimenti
Institutions
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Ospedale Maggiore (IT)
- MultiMedica (IT)
- Ospedale San Giuseppe (IT)
Publication Details
- Journal
- Cancers
- Published
- 2026-04-02
- DOI
- https://doi.org/10.3390/cancers18071151
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Università degli Studi di Milano
- Ministero della Salute